Peter G. Thomson - Net Worth and Insider Trading
Peter G. Thomson Net Worth
The estimated net worth of Peter G. Thomson is at least $8,395 dollars as of 2024-11-13. Peter G. Thomson is the VP Finance & Accounting of Fulcrum Therapeutics Inc and owns about 2,300 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $8,395. Details can be seen in Peter G. Thomson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter G. Thomson has not made any transactions after 2021-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter G. Thomson
Peter G. Thomson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter G. Thomson owns 1 companies in total, including Fulcrum Therapeutics Inc (FULC) .
Click here to see the complete history of Peter G. Thomson’s form 4 insider trades.
Insider Ownership Summary of Peter G. Thomson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | VP Finance & Accounting |
Peter G. Thomson Latest Holdings Summary
Peter G. Thomson currently owns a total of 1 stock. Peter G. Thomson owns 2,300 shares of Fulcrum Therapeutics Inc (FULC) as of June 28, 2021, with a value of $8,395.
Latest Holdings of Peter G. Thomson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | 2,300 | 3.65 | 8,395 |
Holding Weightings of Peter G. Thomson
Peter G. Thomson Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter G. Thomson has made a total of 6 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 2,300 shares on June 28, 2021, which cost Peter G. Thomson around $20,700.
Insider Trading History of Peter G. Thomson
- 1
Peter G. Thomson Trading Performance
GuruFocus tracks the stock performance after each of Peter G. Thomson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter G. Thomson is 206.99%. GuruFocus also compares Peter G. Thomson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter G. Thomson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter G. Thomson's insider trading performs compared to the benchmark.
Performance of Peter G. Thomson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.54 | | | | | |
| Relative Return to S&P 500(%) | -17.1 | | | | | |
Peter G. Thomson Ownership Network
Ownership Network List of Peter G. Thomson
Ownership Network Relation of Peter G. Thomson
Peter G. Thomson Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Peter G. Thomson is the VP Finance & Accounting of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Peter G. Thomson made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Peter G. Thomson Mailing Address
Above is the net worth, insider trading, and ownership report for Peter G. Thomson. You might contact Peter G. Thomson via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
